Moreover, preclinical findings from other groups suggest that tumor microenvironmental patterns could be associated with differential responses to immune checkpoint inhibition, thus distinct microenvironmental features such as tumor-infiltrating CD8+ T cells or CXCL9+ macrophages could complement current patient stratification by PD-L1 expression. This evidence concerns the gene CD274 and neoplasm.